Brief: Yichang HEC Changjiang Pharmaceutical Enters Agreement With Alibaba Health Technology (China)
11/12/2019 14:46
Dec 11 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* ENTERED INTO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT
WITH
ALIBABA HEALTH TECHNOLOGY (CHINA)
* YICHANG HEC CHANGJIANG PHARMACEUTICAL CO LTD - UNDER
AGREEMENT,
CO WILL COOPERATE WITH ALIBABA HEALTH (CHINA) TO CARRY OUT
INFLUENZA SPECIAL PROJECTS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS486cyY
Further company coverage: 1558.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million